Skip to content
drillr.ai
Sign up

ACH

ACCENDRA HEALTH INC/VA/

NYSE · Healthcare · Medical - Distribution · US

$0.22
−6.30%
Ask drillr

  • Oct 9, 2026, 20:15 UTC

    The NYSE notified ACCENDRA HEALTH INC/VA/ that it was not in compliance with Section 802.01C because of its share price; the company said it would consider alternatives to regain compliance, including a reverse stock split subject to stockholder approval.

    Source:

  • Sep 28, 2026, 21:24 UTC

    Accendra Health Inc. announced that Kenneth Gardner-Smith will succeed Edward A. Pesicka as President and Chief Executive Officer effective October 5, 2026, with Pesicka retiring from the CEO and director roles and transitioning to an advisory consulting arrangement.

  • Sep 17, 2026, 10:41 UTC

    Accendra Health Inc. appointed Kenneth Gardner-Smith as President and Chief Executive Officer, succeeding retiring Edward A. Pesicka, and named Scott Lloyd as Chief Commercial Officer effective October 5, 2026.

    Source:

  • Aug 17, 2026, 10:30 UTC

    Accendra Health announced it will not implement an at-the-market equity issuance program due to recent market conditions, abandoning the plan to issue modest amounts of equity over time to reduce debt.

    Source:

  • Aug 10, 2026, 10:50 UTC

    Accendra Health's Board of Directors adopted a Section 382 Rights Agreement (Tax Asset Preservation Plan) to protect its net operating loss carryforwards and other tax attributes, announced on August 10, 2026.

    Source:

  • Aug 10, 2026, 10:45 UTC

    Accendra Health reported its financial results for the second quarter ended June 30, 2026, reflecting continuing operations from its Patient Direct segment.

    Source:

  • Jun 15, 2026, 00:00 UTC

    Accendra Health Inc amended its existing 4.500% Senior Notes due 2029 and 6.625% Senior Notes due 2030, eliminating substantially all affirmative and negative covenants and certain events of default, effective June 15, 2026 after receiving sufficient note holder consents.

  • Jun 14, 2026, 05:57 UTC

    Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO) acquires an additional 12% stake in Arabian Medical Products Manufacturing Co. (ENAYAH) from Accendra Health, Inc., increasing its ownership from 51% to 63%.

    Source:

  • Jun 10, 2026, 10:30 UTC

    Accendra Health announced early results of offers to exchange its 4.500% Senior Notes due 2029 and 6.625% Senior Notes due 2030.

    Source: